Fabricagen to open-source JaxFvLD and AbLanX

The combination of fast structure prediction and differentiable foundation modeling could significantly accelerate therapeutic antibody discovery by enabling end-to-end gradient-based design.

• –JaxFvLD offers rapid sequence-to-structure prediction approaching the performance of IgFold, enabling high-throughput computational screening.
• –AbLanX introduces a differentiable framework, which is crucial for gradient-driven inverse design of antibodies.
• –Releasing these models under an open-source license democratizes access to advanced structural biology tools and fosters community development.